Brokerages Anticipate UFP Technologies, Inc. (NASDAQ:UFPT) to Post $0.56 Earnings Per Share

UFP Technologies, Inc. (NASDAQ:UFPT) has been given a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy rating.

Analysts have set a twelve-month consensus price objective of $44.00 for the company and are forecasting that the company will post $0.56 earnings per share for the current quarter, according to Zacks. Zacks has also assigned UFP Technologies an industry rank of 20 out of 256 based on the ratings given to its competitors.

UFPT has been the subject of several recent analyst reports. ValuEngine raised shares of UFP Technologies from a “hold” rating to a “buy” rating in a report on Thursday, May 9th. BidaskClub raised shares of UFP Technologies from a “sell” rating to a “hold” rating in a report on Wednesday, June 12th. Finally, Zacks Investment Research raised shares of UFP Technologies from a “hold” rating to a “buy” rating and set a $44.00 price objective for the company in a report on Tuesday, June 11th.

In related news, insider R Jeffrey Bailly sold 7,680 shares of the company’s stock in a transaction on Wednesday, June 5th. The shares were sold at an average price of $38.70, for a total transaction of $297,216.00. Following the completion of the sale, the insider now directly owns 495,722 shares of the company’s stock, valued at approximately $19,184,441.40. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Over the last ninety days, insiders have sold 16,219 shares of company stock valued at $626,302. 11.00% of the stock is owned by insiders.

Several hedge funds and other institutional investors have recently bought and sold shares of UFPT. BNP Paribas Arbitrage SA boosted its holdings in shares of UFP Technologies by 545.1% during the 1st quarter. BNP Paribas Arbitrage SA now owns 1,387 shares of the industrial products company’s stock worth $52,000 after buying an additional 1,172 shares during the period. Metropolitan Life Insurance Co. NY bought a new stake in UFP Technologies in the 4th quarter valued at $70,000. MetLife Investment Advisors LLC bought a new stake in UFP Technologies in the 4th quarter valued at $95,000. Alambic Investment Management L.P. bought a new stake in UFP Technologies in the 1st quarter valued at $253,000. Finally, Cubic Asset Management LLC bought a new stake in UFP Technologies in the 1st quarter valued at $291,000. 71.42% of the stock is owned by institutional investors and hedge funds.

Shares of NASDAQ:UFPT traded up $1.39 during trading on Friday, reaching $44.95. The company had a trading volume of 2,922 shares, compared to its average volume of 22,210. The company has a debt-to-equity ratio of 0.15, a current ratio of 2.90 and a quick ratio of 1.88. The business’s fifty day moving average is $41.20. UFP Technologies has a twelve month low of $27.80 and a twelve month high of $43.98. The firm has a market cap of $308.15 million, a price-to-earnings ratio of 21.40 and a beta of 0.53.

UFP Technologies (NASDAQ:UFPT) last released its earnings results on Tuesday, May 7th. The industrial products company reported $0.50 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.10. The business had revenue of $47.33 million for the quarter, compared to the consensus estimate of $45.10 million. UFP Technologies had a net margin of 8.35% and a return on equity of 11.79%. On average, research analysts forecast that UFP Technologies will post 2.22 EPS for the current year.

UFP Technologies Company Profile

UFP Technologies, Inc designs and converts foams, plastics, composites, and natural fiber materials for the medical, automotive, consumer, electronics, industrial, and aerospace and defense markets in the United States. It offers single patient use surfaces, advanced wound care, infection prevention, and disposables for surgical procedures, endoscopic procedures, orthopedic implants, orthopedic appliances, biopharma drug manufacturing, etc.; molded components automotive, aerospace, and defense markets; recycled protective packaging for B2C brands; and reusable cases and custom inserts.

Recommended Story: What is a capital gain?

Get a free copy of the Zacks research report on UFP Technologies (UFPT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for UFP Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UFP Technologies and related companies with MarketBeat.com's FREE daily email newsletter.